콘텐츠로 건너뛰기
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Menu
  • SOLUTIONS
    • Drug Discovery Sevices
    • Collaboration Partners
    • Platform
  • R&D
    • Platform Technology
    • Pipelines
    • Publications
    • Patent & Cert.
  • ABOUT US
    • Overview
    • History
    • Partnership
    • CI & BI
  • NEWS
    • Press Release
    • Seminars & Events
    • Notice
    • Responsibility
  • CAREER
Get In Touch

Press Release

HOME > NEWS > Press Release​

메가존클라우드, 팜캐드와 효율적 신약 개발 위한 양자컴퓨팅 협력 MegazoneCloud and PharmCADD Sign MOU on Quantum Computing for New Drug Development.

READ MORE

정부, 내년 양자 신규사업 7건에 491억원 풀어 | 한국양자산업리더스포럼서 첫 공개…계속사업 17건 포함 총 2004억원 투입

READ MORE

한·일 경제단체 “한국 스타트업 일본 진출 공동 지원”

READ MORE

뿌리 내리는 양자컴퓨팅 기술…AI로 신약 개발 나선다

READ MORE

PharmCADD and partners participated in the “Quantum Korea 2023”

READ MORE

PharmCADD and partners were selected for the 2023 Quantum Computing-Based Challenging Project.

READ MORE

ISU ABXIS-PharmCADD jointly announces “research will provide novel insights to design effective anti-cancer therapeutics for targeting MEK1/2 for neurofibromatosis” in EACR

READ MORE

PharmCADDㆍPNU signed an MOU for Anticancer Drug Development

READ MORE

PharmCADD announced the ‘Biotech Showase 2023’ and ‘RESI conference’ held in San Francisco, USA

READ MORE
« Previous Page1 Page2 Page3 Page4 Page5 Page6 Page7 Page8 Page9 Next »
Headquarters

Address : 224, Engineering Building 7, Sinseon-Ro 365, Namgu, Busan 48548, Republic of Korea
Call : 82-51-747-5681 | Fax : 82-51-747-5682

Seoul Office

Address : 1735, 280, Gwangpyeong-ro, Gangnam-gu, Seoul, Republic of Korea
Call : 82-2-564-5688 | Fax : 82-2-564-5685

E-Mail : [email protected]
Call : 82-51-747-5681
Linkedin-in Youtube

© 2021 PharmCADD. All Rights Reserved.